Measurement of cromakalim-induced 87Rb flux in intact cells by NMR  by Williamson, Michael P.
Volume 254, number 1,2, 171-173 FEB 07549 August 1989 
Measurement of cromakalim-induced *‘Rb flux in intact cells by 
NMR 
Michael P. Williamson 
Roche Products Ltd. PO Box 8, Welwyn Garden City AL 7 3A Y, England 
Received 26 June 1989 
*‘Rb nuclear magnetic resonance signals from intracellular and extracellular Rb+ can be distinguished by the use of shift 
reagents, thus permitting the simultaneous measurement of intracellular and extracellular Rb concentrations. When 
smooth muscle cells are suspended in a medium containing Rbf in place of K+, there is a slow influx of Rb+, which 
is greatly increased by the addition of cromakalim to the medium. The concentration of cromakalim required to stimulate 
influx is similar to that needed to stimulate 86Rb efflux from isolated tissue. 
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1. INTRODUCTION 
There has recently been considerable interest in 
the K+ channel, since the demonstration that a 
number of antihypertensive agents, such as 
cromakalim (BRL 34915), act by opening K+ chan- 
nels (review [I]). Direct measurements of K+ flux 
using 42K+ are difficult, because of the short half- 
life of 42K (12.4 h), and most measurements have 
been performed with s6Rb, which seems to be a 
reasonable substitute for K in many cells [2-41. We 
describe here an NMR-based method for measur- 
ing the flux of *‘Rb, which has advantages over 
s6Rb measurements, in that it does not use radio- 
active nuclei, and it provides simultaneous direct 
measurement of intracellular and extracellular Rb 
concentrations with a time resolution of a few 
minutes [5]. It is based on the use of dys- 
prosium(II1) tripolyphosphate, Dy(PPP), to shift 
signals from extracellular Rb. This method has 
been applied successfully to distinguish intra- and 
extracellular Na en K [6-S] but has so far not been 
applied successfully to Rb, partly because of the 
large linewidth of the Rb signal and the small size 
Correspondence address: M.P. Williamson, Roche Products 
Ltd, PO Box 8, Welwyn Garden City AL7 3AY, England 
of the Dy(PPP)-induced shift. The results obtained 
using this methodology are numerically similar to 
those obtained from *6Rb measurements. 
2. MATERIALS AND METHODS 
2.1. Cell growth and harvesting 
The cells used in these experiments were from the established 
clonal line DDTr MF-2, derived from the ductus deferens of the 
Syrian hamster [9]. They have a number of properties 
characteristic of smooth muscle cells, including possessing 
receptors for err-adrenergic ligands [lo] and leukotriene Cd [ll]. 
They were grown in SO-cm* roller bottles at 37 “C u&g 
Dulbecco’s modified Eagle’s medium (without sodium 
pyruvate) supplemented with 4.5 g/l glucose, 1Vo penicillin/ 
streptomycin and 5% foetal calf serum (all from Gibco). Several 
reports suggest that the growth medium affects the expression of 
ion channels (eg [12]), and therefore to encourage differentia- 
tion once the cells had attained confluence, they were kept in 
medium containing 0.5% foetal calf serum for several days 
prior to harvesting. Preliminary experiments indicated that a 
period of 7-10 days in low serum concentrations was optimal, 
and this was used in all subsequent experiments. Harvesting was 
achieved without the use of trypsin simply by treatment with 
EDTA diamine and produced about 5 x lo7 cells per roller bot- 
tle, of > 95% viability as judged by trypan blue exclusion. 
2.2. NMR experiments 
After harvesting, cells were kept in suspension in the growth 
medium until required (a maximum of 5 h). They were then 
spun down (2 min at 400 x g), washed with buffer, resus- 
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pended, spun down and suspended in buffer at a concentration 
of about 5 x 10’ cells/ml, after which they were placed in a 5 
mm NMR tube and spun down to a pellet in a hand-operated 
centrifuge. The buffer was based on that described in [8], and 
contained 7 mM DyClr, 18.2 mM NasPPP, 10 mM Tris, 10 mM 
glucose, 54 mM NaCl (to give a total Na+ concentration of 
145 mM), and 5 mM RbCl (i.e. replacing all K+ in the original 
buffer by Rb+). It also contained 2 mM CaCls, and was made 
up in 10% DzO on the day and was adjusted to a pH of 7.2. 
87Rb NMR spectra were collected at 37 “C on a Bruker 
AM-400 spectrometer operating at 130.93 MHz, using a 70 “C 
pulse width (approx. 25 rs), a spectral width of 42 kHz and an 
acquisition time of 12 ms. A series of spectra were collected for 
each sample, typically of 20000 scans (4 min) each. Spectra were 
resolution-enhanced with a Lorentz-to-Gaussian transforma- 
tion. 
For each batch of cells, a control spectrum was acquired, 
after which the cells were resuspended, drugs were added, and 
the cells were spun down again. Acquisition of spectra started 
within 1 min of addition of drugs. NMR measurements were 
continued over a period of about 20 min. If no Rb transport was 
observed, the cells were resuspended and a further dose of 
cromakalim was added, after which NMR measurements were 
continued for another 20 min. Thereafter, cells retained >90% 
of their viability, but slowly lost viability over longer periods. 
The cromakalim was prepared by Dr P.B. Kay (Roche). 
3. RESULTS AND DISCUSSION 
The suspension buffer caused a shift of 4 ppm in 
the extracellular *‘Rb resonance frequency, and no 
measurable shift in the intracellular signal, as com- 
pared to an external standard. This shift is smaller 
than the natural linewidth, so resolution enhance- 
ment was necessary to distinguish the two signals. 
In the absence of cromakalim, no intracellular 
signal could be observed initially, but over the 
course of several hours low levels of intracellular 
Rb+ developed, indicating slow transport of Rb 
through the cell membrane. This effect was not suf- 
ficiently rapid to interfere with drug-induced 
measurements, but as a precaution, 20pM ouabain 
was added to the cell suspension just before the ad- 
dition of cromakalim, to inhibit Na+K’-ATPase, 
which has been shown to be the major transport 
system for Rb in a human atria1 cell line [ 131. 
On addition of cromakalim, intracellular Rb 
signals appeared rapidly, and Rb influx was com- 
plete within 10 min. Cromakalim solutions were 
made up in ethanol and diluted with buffer before 
adding to the NMR tube, so that the final ethanol 
concentration was 1% or less. Additions of 
ethanol/buffer mixtures alone had no effect on the 
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NMR spectrum. A rigorous dose dependence rela- 
tionship could not be established, because of the 
low sensitivity of the method, but it was possible to 
determine the minimum concentration required to 
observe Rb influx, which was 1 .O + 0.4 pM. This 
is consistent with the minimum concentration 
needed to stimulate 86Rb efflux in tissue prepara- 
tions, observed by other authors [14,15], which are 
about 5-times those needed for electrical and 
mechanical effects. 
Typical “Rb NMR spectra are shown in fig. 1, in 
which the intracellular/extracellular signal intensi- 
ty ratio after addition of cromakalim is approx. 
1:3. In tightly packed cells, the ratio of in- 
tracellular/extracellular volume is only about 1:2, 
but the cell pellets formed here are not as tightly 
packed as this. We therefore estimate that the 
I 
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Fig.1. 87Rb spectra, with resolution enhancement. (a) RbCl 
solution. (b) Cell suspension in buffer containing Dy(PPP). (c) 
As (b), after the addition of 1 gM chromakalim. Average over 
4-15 min subsequent to addition of cromakalim. The dashed 
lines mark the resonance frequencies of intracellular and 
extracellular Rb, at 0 and -4 ppm, respectively. 
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typical intracellular Rb concentration after addi- 
tion of cromakalim is only slightly greater than the 
extracellular concentration. However, if Rb and K 
are indistinguishable to the cell, the Nernst equa- 
tion predicts that the intracellular Rb concentra- 
tion at equilibrium should reach lo-30-times the 
extracellular level. The reason for the discrepancy 
is not yet clear. 
These measurements are simple and rapid, as 
they do not need a pre-equilibration period in 
which the cells are loaded with Rb. They work in 
the opposite direction to the established methods 
using 86Rb, which measure stimulated dfflux, 
rather than influx. The fact that a smooth muscle 
cell line has been shown to undergo increased Rb 
influx at concentrations of cromakalim similar to 
those needed to stimulate Rb efflux in excised 
tissue opens up the possibility of a novel assay for 
the investigation of K+ channel openers, and fur- 
ther confirms the role of K+ channels in the phar- 
macological action of cromakalim. 
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